"Oxford really understands the life science business and they're more creative, flexible and faster than most of their competitors. We rely on companies like Oxford to extend the cash runway of our portfolio companies, which helps protect our investment. And now that Oxford is a member of the Sumitomo family, our portfolio companies will benefit from the introductions that Oxford can make to key contacts in the Japanese market."

Jonathan MacQuitty, Director & President
Abingworth Management Limited
 
 

"Arch Venture Partners and Oxford have a common goal–we both want to see our portfolio companies succeed. The debt financing offered by Oxford is a practical and creative way for start-up companies to stretch their equity dollars to reach critical benchmarks, which is essential when it comes to securing follow-on equity rounds."

Robert Nelsen, Managing Director
Arch Venture Partners

 
 

"Oxford has an expertise in capital equipment lending that can significantly benefit our portfolio compapnies and, therefore, our venture investments. In addition to its experience in the debt market, Oxford brings the added benefit of an introduction to a very well-respected Japanese industrial and financial conglomerate with multiple interests, including the life science industry. Oxford's relationship with Sumitomo is a key competitive advantage and provides a compelling value proposition for our portfolio companies."

Dr. Jonathan Root, General Partner
U.S. Venture Partners